Remove 2024 Remove Confidentiality Remove Licensing Remove Marketing
article thumbnail

Byte – Sized Battles: Challenges of Deploying AI in Trademark Disputes

Intepat

On April 11, 2024 the United States Patent and Trademark Office (USPTO) issued Guidance on the use of Artificial Intelligence Based Tools (“Guidance”) by applying the existing rules and policies to the use of Artificial Intelligence (AI).

article thumbnail

Biosimilar Regulatory Updates

LexBlog IP

Celltrion Submits BLA for Tocilizumab Biosimilar On January 28, 2024, Celltrion USA announced that it has completed submission of its application to the FDA for CT-P47, its proposed tocilizumab biosimilar. Aflibercept is used in the treatment of neovascular age-related macular degeneration and other retinal diseases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bevacizumab and Trastuzumab Biosimilars Case Continues, With No End in Sight  

SpicyIP

The Indian pharmaceutical landscape has seen the emergence of biosimilars like Bevacizumab and Trastuzumab (used as first-line treatment of advanced HER2-positive gastric cancer ) commanding a market worth around 640 crores. The next date of hearing is scheduled for July 26, 2024. [H/T H/T to Prashant Reddy T.

article thumbnail

Dragons' Den IP Blog - Series 21 Episode 6

Dragons' Den

What is its appeal to the market? In IPO’s free, online, easy to use toolkit there are resources designed to help businesses identify their IP and understand how to protect, manage it and even license it to scale up their product. They spoke about wanting to scale up their business, and one way of achieving this is through licensing.

article thumbnail

SpicyIP Weekly Review (February 26- March 3)

SpicyIP

Case Summaries BMI Group Danmark Aps vs The Assistant Controller Of Patents on 22 February, 2024 (Delhi High Court) Image from here An appeal was filed against the impugned order rejecting the suit patent for lack of an inventive step. The Court also directed the applicant to pay INR 25 thousand as costs, though later waived this direction.

article thumbnail

SpicyIP Weekly Review (March 4-March 10)

SpicyIP

Case Summaries Therelek Machines Private Limited vs Therelek Engineers Private Limited on 28 February, 2024 (Karnataka High Court) The petitioner challenged the rejection of its interim application under Section 124 of the Trade Marks Act, seeking a stay in a suit for trademark infringement.

article thumbnail

Health Data: European Commission Proposes new Rules on Access and Use

LexBlog IP

The European Commission’s aim is to adopt the EHDS by the end of its current mandate (October 31, 2024). If approved, the EHDS proposal would introduce a new regime for the compulsory licensing of health data to third parties.